Topical nepafenac in the treatment of diabetic macular edema
David Callanan, Patrick WilliamsTexas Retina Associates, Arlington, TX, USAPurpose: To determine the safety and efficacy of topical nepafenac 0.1% in the treatment of diabetic macular edema.Methods: A consecutive case series was performed of patients treated with nepafenac monotherapy twice daily fo...
Saved in:
Main Authors: | David Callanan, Patrick Williams |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/abae7a7b616b4abd96dbec2d63fb594a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
by: Seenu M Hariprasad, et al.
Published: (2009) -
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
by: Singh R, et al.
Published: (2012) -
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
by: Yüksel B, et al.
Published: (2017) -
Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
by: Bruce I Gaynes, et al.
Published: (2008) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
by: Dugel PU, et al.
Published: (2015)